PCSA · Processa Pharmaceuticals, Inc. · Documents
$1.81
-0.05 (-2.69%)
At close · Oct 23
Return incl. dividend (before tax)
Going-concern doubt
— cleared Aug 14, 2026
The latest filing states the doubt was alleviated.
“Following our acquisition of Vidya and closing of the related $200 million gross private placement (from which we received net proceeds of $183.3 million) on July 30, 2026, we believe our cash and cash equivalents will be sufficient to satisfy our cash requirements over the next 12 months and beyond. This represents a material change from what we reported in our 2025 Form 10-K that disclosed substantial doubt of our ability to continue as a going concern.”View the 10-Q filed Aug 14, 2026
Market Cap
$5.06M
Shares
2.79M
Volume · Oct 23
35.05K
Avg daily vol (3M)
266.29K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 8-K | — | 2023-03-22 | — | |
| 8-K | — | 2023-03-14 | — | |
| 8-K | — | 2023-02-13 | 2023-02-09 | |
| 8-K | — | 2023-02-06 | — | |
| 8-K | — | 2023-01-09 | — | |
| 8-K | — | 2022-12-22 | — | |
| 8-K | — | 2022-12-14 | — | |
| 10-Q | — | 2022-11-08 | 2022-09-30 | |
| 8-K | — | 2022-11-08 | — | |
| 8-K | — | 2022-11-04 | 2022-11-02 | |
| 8-K | — | 2022-09-07 | — | |
| 8-K | — | 2022-08-12 | — | |
| 10-Q | — | 2022-08-11 | 2022-06-30 | |
| 8-K | — | 2022-08-04 | — | |
| 8-K | — | 2022-07-25 | 2022-07-19 | |
| 8-K | — | 2022-07-14 | 2022-07-11 | |
| DEFA14A | — | 2022-05-31 | — | |
| DEF 14A | — | 2022-05-31 | — | |
| 8-K | — | 2022-05-16 | — | |
| 10-Q | — | 2022-05-12 | 2022-03-31 | |
| 8-K | — | 2022-05-12 | — | |
| 10-K/A | — | 2022-05-02 | 2021-12-31 | |
| 10-K | — | 2022-03-30 | 2021-12-31 | |
| 8-K | — | 2022-03-24 | 2022-03-23 | |
| 8-K | — | 2022-03-17 | — | |
| 8-K | — | 2022-01-26 | — | |
| 8-K | — | 2022-01-06 | 2022-01-01 | |
| 10-Q | — | 2021-11-12 | 2021-09-30 | |
| 8-K | — | 2021-11-05 | 2021-11-03 | |
| DEF 14A | — | 2021-09-20 | — | |
| DEFA14A | — | 2021-09-20 | — | |
| 8-K | — | 2021-09-20 | — | |
| PRE 14A | — | 2021-09-01 | — | |
| 8-K | — | 2021-08-20 | — | |
| 8-K | — | 2021-08-13 | 2021-08-12 | |
| 10-Q | — | 2021-08-12 | 2021-06-30 | |
| 8-K | — | 2021-07-30 | 2021-07-29 | |
| 8-K | — | 2021-07-15 | — | |
| S-3 | — | 2021-06-30 | — | |
| 8-K | — | 2021-06-17 | 2021-06-16 | |
| 8-K | — | 2021-06-10 | — | |
| 8-K | — | 2021-06-09 | — | |
| 8-K | — | 2021-05-26 | 2021-05-25 | |
| 8-K | — | 2021-05-20 | — | |
| 8-K | — | 2021-05-13 | — | |
| 10-Q | — | 2021-05-13 | 2021-03-31 | |
| DEFA14A | — | 2021-04-26 | — | |
| DEF 14A | — | 2021-04-22 | — | |
| 10-K/A | — | 2021-04-07 | 2020-12-31 | |
| S-3 | — | 2021-04-02 | — |
Showing 101–150 of 174 filings